Clinical Trial Update: Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC) [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov entry updates a Phase 1 trial (DYNAMIC) evaluating allogeneic myocardial-regenerative cells (CAP-1002) for dilated cardiomyopathy and ot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Heart Failure
• Ischemic Cardiomyopathy
• Nonischemic Cardiomyopathy

Drugs mentioned

• CAP-1002 (cardiosphere-derived cells)

Snippet

Sponsor: Capricor Inc. | Conditions: Dilated Cardiomyopathy (DCM), Ischemic Cardiomyopathy | Phase 1 | Status: UNKNOWN